Actively Recruiting
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
Led by Imperial College London · Updated on 2024-07-03
160
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people with type 2 diabetes facilitates time in glycaemic range in the 6 months after an acute myocardial infarction. As an exploratory outcome it will investigate whether time in glycaemic range is associated with changes in mortality and major adverse cardiac events in the 6 months after acute myocardial infarct.
CONDITIONS
Official Title
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged >18 years
- Known or newly diagnosed type 2 diabetes
- Taking one or more oral hypoglycaemic agents, GLP1 receptor analogue and/or insulin
- Admitted to Hammersmith Hospital cardiology inpatient services with acute coronary syndrome
- Raised blood troponin level on admission
- Adults aged >18 years
- Known type 2 diabetes
- Previous acute coronary syndrome within the last 10 years but >6 months ago
- Taking one or more oral hypoglycaemic agents and/or GLP1 receptor analogue, and/or insulin
You will not qualify if you...
- HbA1c <48mmol/mol
- Previous bariatric surgery
- Taking hydroxyurea
- Undergoing haemodialysis or peritoneal dialysis
- Unable to participate due to other factors as assessed by the Chief Investigators
- Pregnancy as determined by clinical team
- Known terminal condition or life expectancy less than 1 year
- Previous acute coronary syndrome more than 10 years ago or within the last 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hammersmith Hospital inpatient cardiology services
London, United Kingdom
Actively Recruiting
Research Team
M
Monika Reddy, MBChB, PhD
CONTACT
N
Nick Oliver, MB BS, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here